151 related articles for article (PubMed ID: 38164156)
1. Vitamin D binding protein (VDBP) hijacks twist1 to inhibit vasculogenic mimicry in hepatocellular carcinoma.
Qin LN; Zhang H; Li QQ; Wu T; Cheng SB; Wang KW; Shi Y; Ren HR; Xing XW; Yang C; Sun T
Theranostics; 2024; 14(1):436-450. PubMed ID: 38164156
[No Abstract] [Full Text] [Related]
2. Androgen receptor suppresses vasculogenic mimicry in hepatocellular carcinoma via circRNA7/miRNA7-5p/VE-cadherin/Notch4 signalling.
Bao S; Jin S; Wang C; Tu P; Hu K; Lu J
J Cell Mol Med; 2020 Dec; 24(23):14110-14120. PubMed ID: 33118329
[TBL] [Abstract][Full Text] [Related]
3. Polyphyllin I suppresses the formation of vasculogenic mimicry via Twist1/VE-cadherin pathway.
Xiao T; Zhong W; Zhao J; Qian B; Liu H; Chen S; Qiao K; Lei Y; Zong S; Wang H; Liang Y; Zhang H; Meng J; Zhou H; Sun T; Liu Y; Yang C
Cell Death Dis; 2018 Sep; 9(9):906. PubMed ID: 30185783
[TBL] [Abstract][Full Text] [Related]
4. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry.
Sun T; Zhao N; Zhao XL; Gu Q; Zhang SW; Che N; Wang XH; Du J; Liu YX; Sun BC
Hepatology; 2010 Feb; 51(2):545-56. PubMed ID: 19957372
[TBL] [Abstract][Full Text] [Related]
5. Hsp90β promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.
Meng J; Chen S; Lei YY; Han JX; Zhong WL; Wang XR; Liu YR; Gao WF; Zhang Q; Tan Q; Liu HJ; Zhou HG; Sun T; Yang C
Oncogene; 2019 Jan; 38(2):228-243. PubMed ID: 30087438
[TBL] [Abstract][Full Text] [Related]
6. COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling.
Jue C; Min Z; Zhisheng Z; Lin C; Yayun Q; Xuanyi W; Feng J; Haibo W; Youyang S; Tadashi H; Shintaro I; Shiyu G; Yanqing L
J Ethnopharmacol; 2017 Aug; 208():165-173. PubMed ID: 28694103
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia induced epithelial-mesenchymal transition and vasculogenic mimicry formation by promoting Bcl-2/Twist1 cooperation.
Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
Exp Mol Pathol; 2015 Oct; 99(2):383-91. PubMed ID: 26318343
[TBL] [Abstract][Full Text] [Related]
8. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
Jue C; Lin C; Zhisheng Z; Yayun Q; Feng J; Min Z; Haibo W; Youyang S; Hisamitsu T; Shintaro I; Shiyu G; Yanqing L
Oncotarget; 2017 Jan; 8(2):2501-2513. PubMed ID: 27705934
[TBL] [Abstract][Full Text] [Related]
9. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
Zheng N; Zhang S; Wu W; Zhang N; Wang J
Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
Zhao X; Sun B; Liu T; Shao B; Sun R; Zhu D; Zhang Y; Gu Q; Dong X; Liu F; Zhao N; Zhang D; Li Y; Meng J; Gong W; Zheng Y; Zheng X
Cancer Sci; 2018 Oct; 109(10):3197-3208. PubMed ID: 30022558
[TBL] [Abstract][Full Text] [Related]
11. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of vasculogenic mimicry immunohistochemical expression in hepatocellular carcinoma.
Guzman G; Cotler SJ; Lin AY; Maniotis AJ; Folberg R
Arch Pathol Lab Med; 2007 Dec; 131(12):1776-81. PubMed ID: 18081435
[TBL] [Abstract][Full Text] [Related]
13. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.
Cheng R; Cai XR; Ke K; Chen YL
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):719-725. PubMed ID: 29058285
[TBL] [Abstract][Full Text] [Related]
14. The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib.
Zhang X; Zhang JG; Mu W; Zhou HM; Liu GL; Li Q
Phytomedicine; 2021 Nov; 92():153740. PubMed ID: 34600176
[TBL] [Abstract][Full Text] [Related]
15. Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma.
Meng J; Sun B; Zhao X; Zhang D; Zhao X; Gu Q; Dong X; Zhao N; Liu P; Liu Y
Mol Cancer Ther; 2014 Dec; 13(12):3107-22. PubMed ID: 25277383
[TBL] [Abstract][Full Text] [Related]
16. [MIG7 Regulates the Vasculogenic Mimicry Formation in Hepatocellular Carcinoma then Effects the Metastasis Potential of HCC].
Qu B; Yu F; Sheng GN; Chen GN; Lü Q; Gu YJ; Guo L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 May; 48(3):373-377. PubMed ID: 28616909
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia promotes vasculogenic mimicry formation by the Twist1-Bmi1 connection in hepatocellular carcinoma.
Liu K; Sun B; Zhao X; Wang X; Li Y; Qiu Z; Liu T; Gu Q; Dong X; Zhang Y; Wang Y; Zhao N
Int J Mol Med; 2015 Sep; 36(3):783-91. PubMed ID: 26202447
[TBL] [Abstract][Full Text] [Related]
18. Flavokawain A suppresses the vasculogenic mimicry of HCC by inhibiting CXCL12 mediated EMT.
Xiao T; Bao J; Tian J; Lin R; Zhang Z; Zhu Y; He Y; Gao D; Sun R; Zhang F; Cheng Y; Shaletanati J; Zhou H; Xie C; Yang C
Phytomedicine; 2023 Apr; 112():154687. PubMed ID: 36804756
[TBL] [Abstract][Full Text] [Related]
19. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
[TBL] [Abstract][Full Text] [Related]
20. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
